Comparative Study of Intralesional Dexamethasone, Hyaluronidase and Oral Pentoxifylline in Patients with Oral Submucous Fibrosis
Keywords:
Oral submucous fibrosis, pentoxifylline, Dexamethasone, Hyaluronidase Lignocaine, burning sensation, mouth opening, tongue protrusion, cheek flexibili
Abstract
Back ground : Oral submucous fibrosis (OSF) is characterized by excessive production of collagen leading to inelasticity of the oral mucosa and atrophic changes of the epithelium. Aim : Aim of the study is to clinically evaluate the efficacy of oral Pentoxifylline 400 mg tablets in comparison to intralesional injections of Dexamethasone (4mg/ml) and Hyaluronidase 1500 IU and 0.5 ml of Lignocaine 2% in the management of OSF patients. Methodology : The study population consisted of 40 male patients with OSF. Patients were divided into two groups. 20 patients are in pentoxifylline group and 20 patients in Dexamethasone group. Pentoxifylline Group received oral Pentoxifylline 400 mg tablets twice daily for first 4 weeks and thrice daily for next 8 weeks. Dexamethasone Group received biweekly intralesional injections of Dexamethasone (4mg/ml), Hyaluronidase 1500 IU and 0.5 ml of Lignocaine 2% for a period of 12 weeks. Parameters taken in the study were burning sensation, mouth opening, tongue protrusion and cheek flexibility.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2012-03-15
Issue
Section
License
Copyright (c) 2012 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.